- List
- By Topic
- On Map
- Search Details
Study record managers: refer to the Data Element Definitions if submitting registration or results information.
x
1 | NCT02488759 | Recruiting | An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors |
|
|
Interventional |
Phase 1 Phase 2 |
|
Industry |
|
|
600 | All | 18 Years and older (Adult, Older Adult) | NCT02488759 | CA209-358 2015-000230-29 |
CheckMate358 | October 8, 2015 | May 13, 2019 | December 31, 2019 | July 2, 2015 | October 19, 2018 |
|